Common Cold Antibodies May Hinder Defense Against SARS-CoV-2

Antibodies to common-cold viruses, collectively known as hCoV, may hamper the body's response to SARS-CoV-2, according to new data. Earlier studies have disagreed on whether previously acquired hCoV antibodies protect against SARS-CoV-2 infection.
Reuters Health Information

source https://www.medscape.com/viewarticle/964683?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

A case report of pudendal arteries angioplasty with sirolimus drug-coated balloon and drug-eluting stent associated with intracavernous autologous peripheral blood mononuclear cells injection for untreatable vasculogenic erectile dysfunction.